Inovio Pharmaceuticals Aims To Have More Than 1 Million COVID19 Vaccines By End Of Year

Inovio Pharmaceuticals CEO on virus vaccine human trials, completing volunteer enrollment in AprilПодробнее

Inovio PharmaceuticalsПодробнее

INOVIO Pharmaceuticals initiates phase one human clinical trial for COVID-19 vaccineПодробнее

Coronavirus: Inovio Pharmaceuticals CEO talks conducting vaccine trialsПодробнее

Inovio Pharmaceuticals Aims To Have More Than 1 Million COVID19 Vaccines By End Of YearПодробнее

San Diego's Inovio working to develop universal COVID-19 vaccineПодробнее

Covid-19 Vaccine Could Be Available This Year, Inovio Co-Founder SaysПодробнее

Inovio’s COVID19 VaccineПодробнее

WHO Says 70 Vaccines in the Works, With Three Leading CandidatesПодробнее

INOVIO begins phase 1 clinical trial for vaccineПодробнее

INOVIO DNA Immunotherapy and GBMПодробнее

Promising results for InovioПодробнее

How a Covid-19 Vaccine Human Trial WorksПодробнее

Inovio's COVID-19 Vaccine Set To Go Through Critical Stage Three TrialПодробнее

INOVIO DNA Medicine MOAПодробнее

When to expect public access to COVID-19 vaccinationsПодробнее

Kate Broderick: INO-4800 – A DNA based vaccine against COVID-19Подробнее

Advantages of DNA Vaccines in Response to the COVID-19 OutbreakПодробнее

DNA Medicines: From COVID-19 to CancerПодробнее

Inovio - Infectious DiseasesПодробнее